Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
This clinical trial is for men and women with resectable or metastatic solid tumor malignancies. The objective of the study is to investigate whether high dose vitamin C infusion leads to pathological tumor response in resectable colorectal, pancreatic, and lung cancers.
Patients will receive high dose Vitamin C infusion for 4 days per week for 2-4 consecutive weeks prior to surgery. A tumor sample will be resected after completion of study drug (high dose vitamin C infusion) treatment to examine the effects of study drug. In addition, organoids will be grown in vitro and continue to be treated with vitamin C added in culture medium to examine tumor response.
Detailed eligibility reviewed when you contact the study team.